Targeting Streptococcus salivarius in Peri-Implantitis
Two Antimicrobial and Antibiofilm Peptides
DOI:
https://doi.org/10.17161/mjusc.v4i1.24547Palavras-chave:
Dental, Streptococcus, implant, periimplantitis, peptideResumo
Peri-implantitis, a persistent complication associated with dental implants, is driven by complex, antibiotic-resistant oral biofilms. Antimicrobial Peptides (AMPs) may represent novel, safe, and effective therapies against Streptococcus salivarius, a key early colonizer in peri-implant biofilms. S. salivarius was isolated and identified by 16S sequencing from human saliva, followed by standardized growth and biofilm assays to establish a physiologically relevant testing model. RR12 is a novel peptide that was rationally designed, synthesized, and characterized for structural integrity for comparison against KR12, a natural LL-37 derivative known to be effective against bacteria. Both peptides demonstrated dose-dependent inhibition of S. salivarius biofilm formation, but KR12 consistently achieved superior antimicrobial and antibiofilm effects with lower cytotoxicity. These findings underscore the necessity of biological validation in peptide development and support the use of AMPs as promising alternatives to traditional antibiotics. AMP-based coatings and gels for dental implants could offer localized, resistance-proof infection control.
Referências
. Berger, D., Rakhamimova, A., Pollack, A. & Loewy, Z. Oral Biofilms: Development, Control, and Analysis. High-Throughput 7, 24 (2010).
2. Körtvélyessy, G., Tarjányi, T., Baráth, Z. L., Minarovits, J. & Tóth, Z. Bioactive coatings for dental implants: A review of alternative strategies to prevent peri-implantitis induced by anaerobic bacteria. Anaerobe 70, 12404 (2021).
3. Roger, P., Delettre, J., Bouix, M. & Béal, C. Characterization of Streptococcus salivarius growth and maintenance in artificial saliva. J. Appl. Microbiol. 111, 631–641 (2011).
4. Patras, K. A. et al. Streptococcus salivarius K12 Limits Group B Streptococcus Vaginal Colonization. Infect. Immun. 83, 3438–3444 (2015).
5. Zhuo, H., Zhang, X., Li, M., Zhang, Q. & Wang, Y. Antibacterial and Anti-Inflammatory Properties of a Novel Antimicrobial Peptide Derived from LL-37. Antibiot. Basel Switz. 11, 754 (2022).
6. Vertillo Aluisio, G. et al. Streptococcus salivarius 24SMBc Genome Analysis Reveals New Biosynthetic Gene Clusters Involved in Antimicrobial Effects on Streptococcus pneumoniae and Streptococcus pyogenes. Microorganisms 10, 2042 (2022).
7. Wang, Z., Shen, Y. & Haapasalo, M. Antibiofilm peptides against oral biofilms. J. Oral Microbiol. 9, 1327308 (2017).
8. Khurshid, Z. et al. Oral antimicrobial peptides: Types and role in the oral cavity. Saudi Pharm. J. SPJ Off. Publ. Saudi Pharm. Soc. 24, 515–524 (2016).
9. Li, J. et al. Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design. Front. Neurosci. 11, 73 (2017).
10. Calabrese, E. J. & Mattson, M. P. Hormesis provides a generalized quantitative estimate of biological plasticity. J. Cell Commun. Signal. 5, 25–38 (2011).
11. Mahlapuu, M., Håkansson, J., Ringstad, L. & Björn, C. Antimicrobial peptides: an emerging category of therapeutic agents. Front. Cell. Infect. Microbiol. 6, 194 (2016)
12. Nguyen, L.T., Haney, E.F. & Vogel, H.J. The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol. 29, 464–472 (2011).
13. Fjell, C.D., Hiss, J.A., Hancock, R.E.W. & Schneider, G. Designing antimicrobial peptides: form follows function. Nat. Rev. Drug Discov. 11, 37–51 (2012).
14. Castillo-Juárez, I., Blancas-Luciano, B. E., García-Contreras, R. & Fernández-Presas, A. M. Antimicrobial peptides properties beyond growth inhibition and bacterial killing. PeerJ 10, e12667 (2022).
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2025 Samia Chergui, Sonia Thomas, Melissa Daggett, Brendan Mattingly, Jack Treml
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial 4.0 International License.
© The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license.
